Your browser doesn't support javascript.
loading
Automated ELISA on-chip for the detection of an-ti-SARS-CoV-2 antibodies
Everardo Gonzalez-Gonzalez Sr.; Ricardo Garcia-Ramirez; Gladys Guadalupe Diaz Armas; Miguel Esparza; Carlos Aguilar-Avelar; Elda A. Flores-Contreras; Iram Pablo Rodriguez-Sanchez; Jesus Rolando Delgado-Balderas; Brenda Soto-Garcia; Diana Araiz-Hernandez; Marisol Abarca-Blanco; Jose R. Yee-de Leon; Liza P. Velarde-Calvillo; Alejandro Abarca-Blanco; Juan F. Yee-de Leon.
Afiliação
  • Everardo Gonzalez-Gonzalez Sr.; Tecnologico de Monterrey
  • Ricardo Garcia-Ramirez; Delee Corp
  • Gladys Guadalupe Diaz Armas; Delee Corp
  • Miguel Esparza; Delee Corp
  • Carlos Aguilar-Avelar; Delee Corp
  • Elda A. Flores-Contreras; Universidad Autonoma de Nuevo Leon
  • Iram Pablo Rodriguez-Sanchez; Universidad Autonoma de Nuevo Leon
  • Jesus Rolando Delgado-Balderas; Delee Corp
  • Brenda Soto-Garcia; Delee Corp
  • Diana Araiz-Hernandez; Delee Corp
  • Marisol Abarca-Blanco; Delee Corp
  • Jose R. Yee-de Leon; Delee Corp
  • Liza P. Velarde-Calvillo; Delee Corp
  • Alejandro Abarca-Blanco; Delee Corp
  • Juan F. Yee-de Leon; Delee Corp
Preprint em En | PREPRINT-MEDRXIV | ID: ppmedrxiv-21261664
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
The COVID-19 pandemic has been the most critical public health issue in modern his-tory due to its highly infectious and deathly potential; and the limited access to massive, low-cost, and reliable testing has significantly worsened the crisis. The recovery and the vaccination of millions of people against COVID-19, have made serological tests highly relevant to identify the presence and levels of SARS-CoV-2 antibodies. Due to its advantages, microfluidic-based technologies represent an attractive alternative to the conventional testing methodologies used for these purposes. In this work, we describe the development of an automated ELISA on-chip capable of detecting anti-SARS-CoV-2 antibodies in serum samples from COVID-19 patients and vaccinated individuals. The colorimetric reactions were analyzed with a microplate reader. No statistically significant differences were observed when comparing the results of our automated ELISA on-chip against the ones obtained from a traditional ELISA on a microplate. Moreover, we demonstrated that it is possible to carry out the analysis of the colorimetric reaction by performing basic image analysis of photos taken with a smartphone, which constitutes a useful alternative when lacking specialized equipment or a laboratory setting. Our automated ELISA on-chip has the potential to be used in a clinical setting and mitigate some of the burden caused by testing deficiencies.
Licença
cc_by_nc_nd
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Preprint